Abstract

Summary

This controlled study found no significant difference in melatonin suppression responses to melanopsin-weighted light between euthymic bipolar I patients and healthy controls, challenging the hypothesis that light hypersensitivity is a biomarker of bipolar disorder. For lighting designers and clinicians, this suggests that standard circadian lighting protocols likely do not need to be specifically modified for bipolar I patients based on differential melatonin suppression sensitivity alone.
Abstract

Key Findings

  • No statistically significant difference in melatonin suppression to melanopsin-weighted light was found between bipolar I disorder patients and healthy controls.
  • Results do not support light-induced melatonin supersensitivity as a valid endophenotype for bipolar I disorder.
  • Study used a large cohort under highly controlled laboratory conditions, strengthening the reliability of the null finding.
Categories

Categories

Sleep & Circadian Health: Examines melatonin suppression responses to melanopsin-weighted light, directly relevant to circadian photosensitivity in bipolar disorder.
Mood & Mental Wellness: Tests whether light-induced melatonin supersensitivity is a valid endophenotype for bipolar I disorder.
The Science of Light: Uses melanopsin-weighted (melanopic) light stimuli under highly controlled laboratory conditions to assess photoreceptor-driven melatonin suppression.
Authors

Author(s)

P Ritter, F Wieland, DJ Skene, A Pfennig, M Weiss
Publication Date

Publication Year

2020
Citations

Number of Citations

23
View more publications